---
figid: PMC2720036__nihms87447f1
figtitle: Selective Raf Inhibition in Cancer Therapy
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC2720036
filename: nihms87447f1.jpg
figlink: /pmc/articles/PMC2720036/figure/F1/
number: F1
caption: 'Components of the central activation cascade proceeding from ligand-bound
  EGFR through Raf to the nucleus are indicated in green or yellow boxes, connected
  by red arrows. Additional proteins regulating Raf are indicated in gray boxes. Additional
  Raf phosphorylated/regulated proteins beyond the central cascade are indicated in
  pink boxes: not all are shown (see text). After Ras stimulation, B-Raf heterodimerizes
  with c-Raf-1; mutationally activated B-Raf binds and activates C-Raf and MEK independent
  of Ras []. Therapeutics targeting B-Raf and c-Raf1 are the predominant topic of
  this review: agents targeting EGFR and MEK1 are also briefly discussed.'
papertitle: Selective Raf Inhibition in Cancer Therapy.
reftext: Vladimir Khazak, et al. Expert Opin Ther Targets. ;11(12):1587-1609.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9166933
figid_alias: PMC2720036__F1
figtype: Figure
redirect_from: /figures/PMC2720036__F1
ndex: 2fe03eb5-df0f-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2720036__nihms87447f1.html
  '@type': Dataset
  description: 'Components of the central activation cascade proceeding from ligand-bound
    EGFR through Raf to the nucleus are indicated in green or yellow boxes, connected
    by red arrows. Additional proteins regulating Raf are indicated in gray boxes.
    Additional Raf phosphorylated/regulated proteins beyond the central cascade are
    indicated in pink boxes: not all are shown (see text). After Ras stimulation,
    B-Raf heterodimerizes with c-Raf-1; mutationally activated B-Raf binds and activates
    C-Raf and MEK independent of Ras []. Therapeutics targeting B-Raf and c-Raf1 are
    the predominant topic of this review: agents targeting EGFR and MEK1 are also
    briefly discussed.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - rp
  - Shc
  - Src42A
  - Csk
  - Src64B
  - cas
  - caz
  - Cse1
  - cass
  - cash
  - drk
  - Rap1
  - Rac1
  - Rac2
  - Akt
  - Mtl
  - Sos
  - ras
  - Ras64B
  - Ras85D
  - Pak
  - mbt
  - Hsp83
  - Gp93
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - twe
  - stg
  - 14-3-3zeta
  - 14-3-3epsilon
  - rb
  - Ask1
  - Debcl
  - rl
  - S6kII
  - Dif
  - dl
  - Rel
  - Myc
  - kay
  - CrebB
  - CrebA
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - SRC
  - FGR
  - FYN
  - YES1
  - CSE1L
  - CTNND1
  - BCAR1
  - TMX2-CTNND1
  - GRB2
  - RAP1A
  - RABGEF1
  - TERF2IP
  - RAP1B
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - HRAS
  - NRAS
  - PEBP1
  - PAK1
  - PAK2
  - PAK3
  - PAK4
  - PAK5
  - PAK6
  - HSP90AA1
  - HSP90B1
  - TRAP1
  - HSP90AB1
  - PPA2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - BRAF
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - AKT2
  - AKT3
  - CDC25C
  - RASGRF1
  - CDC25A
  - CDC25B
  - YWHAQ
  - RAF1
  - BAD
  - BAG1
  - MAP2K1
  - MAP3K5
  - BCL2
  - MAPK3
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - RPS6KB1
  - RPS6KB2
  - NFKB1
  - ABCB1
  - TBC1D9
  - CCND1
  - MYC
  - FOS
  - ELK1
  - KCNH4
  - KCNH8
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - Cancer
  - Lung cancer
  - Noonan syndrome
---
